| 臺大學術典藏 |
2022-05-02T02:52:43Z |
Anxiety, depression and related factors in family caregivers of newly diagnosed lung cancer patients before first treatment
|
YUN-HSIANG LEE; Liao Y.-C.; Liao W.-Y.; Shun S.-C.; Liu Y.-C.; Chan J.-C.; Yu C.-J.; Yang P.-C.; Lai Y.-H. |
| 臺大學術典藏 |
2022-05-02T02:52:42Z |
Trajectories of caregiver burden and related factors in family caregivers of patients with lung cancer
|
YUN-HSIANG LEE; Liao Y.-C.; Shun S.-C.; Lin K.-C.; Liao W.-Y.; Chang P.-H.; Jhang S.-Y.; Yu C.-J.; Yang P.-C.; Hsieh P.-Y.; Lai Y.-H. |
| 臺大學術典藏 |
2022-04-28T08:06:40Z |
Symptoms, psychological distress, and supportive care needs in lung cancer patients
|
Liao Y.-C.; Liao W.-Y.; Shun S.-C.; Yu C.-J.; Yang P.-C.; YEUR-HUR LAI |
| 臺大學術典藏 |
2022-04-28T08:06:38Z |
Anxiety, depression and related factors in family caregivers of newly diagnosed lung cancer patients before first treatment
|
Lee Y.-H.; Liao Y.-C.; Liao W.-Y.; Shun S.-C.; Liu Y.-C.; Chan J.-C.; Yu C.-J.; Yang P.-C.; YEUR-HUR LAI |
| 臺大學術典藏 |
2022-04-28T08:06:36Z |
Quality of life and related factors in patients with newly diagnosed advanced lung cancer: A longitudinal study
|
Liao Y.-C.; Shun S.-C.; Liao W.-Y.; Yu C.-J.; Yang P.-C.; YEUR-HUR LAI |
| 臺大學術典藏 |
2022-04-28T08:06:30Z |
The unmet supportive care needs—what advanced lung cancer patients’ caregivers need and related factors
|
Chen S.-C.; Chiou S.-C.; Yu C.-J.; Lee Y.-H.; Liao W.-Y.; Hsieh P.-Y.; Jhang S.-Y.; YEUR-HUR LAI |
| 臺大學術典藏 |
2022-04-28T08:06:27Z |
Trajectories of caregiver burden and related factors in family caregivers of patients with lung cancer
|
Lee Y.-H.; Liao Y.-C.; Shun S.-C.; Lin K.-C.; Liao W.-Y.; Chang P.-H.; Jhang S.-Y.; Yu C.-J.; Yang P.-C.; Hsieh P.-Y.; YEUR-HUR LAI |
| 臺大學術典藏 |
2022-03-09T03:12:36Z |
TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer
|
Ho C.-C.; Liao W.-Y.; Wang C.-Y.; Lu Y.-H.; Huang H.-Y.; Chen H.-Y.; Chan W.-K.; HUEI-WEN CHEN; Yang P.-C. |
| 臺大學術典藏 |
2022-03-04T05:33:49Z |
The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms
|
Chang Y.-L.; Lee Y.-C.; Liao W.-Y.; CHEN-TU WU |
| 臺大學術典藏 |
2022-03-04T05:33:28Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; CHEN-TU WU; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-03-04T05:33:27Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; CHEN-TU WU; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-03-04T03:48:05Z |
Tubulointerstitial nephritis associated with erlotinib therapy for lung cancer
|
Cho S.-L.; WEI-CHOU LIN; Chuang C.-A.; Liao W.-Y.; Lai C.-F. |
| 臺大學術典藏 |
2022-02-21T03:52:35Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; JIH-HSIANG LEE; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:35Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:34Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non�VSmall-cell Lung Cancer Patients
|
Wu T.-H.; Hsiue E.H.-C.; JIH-HSIANG LEE; Lin C.-C.; Liao W.-Y.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:33Z |
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors
|
JIH-HSIANG LEE; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; Liao W.-Y.; Shih J.-Y.; Yu C.-J.; Chen K.-Y.; Tsai T.-H.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:33Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; JIH-HSIANG LEE; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:32Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:31Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:30Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M�VPositive NSCLC
|
Liao B.-C.; Hsu W.-H.; JIH-HSIANG LEE; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-14T07:10:40Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 國立成功大學 |
2022 |
Mesh-free simulation of two-phase fluid flow in porous media based on the shock-fitting method
|
Lee, E.-J.;Wang, Wang W.;Chen, P.;Jiao, Z.;Gong, Y.;Mu, D.;Liao, W.-Y. |
| 臺大學術典藏 |
2021-11-03T05:24:55Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC
|
Liao B.-C.; Hsu W.-H.; Lee J.-H.; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; CHONG-JEN YU; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-11-03T05:24:54Z |
Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan
|
Wu S.-G.; Liao W.-Y.; Su K.-Y.; Yu S.-L.; Huang Y.-L.; CHONG-JEN YU; Chih-Hsin Yang J.; Shih J.-Y. |
| 臺大學術典藏 |
2021-11-03T02:33:02Z |
Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan
|
Wu S.-G.; Liao W.-Y.; Su K.-Y.; Yu S.-L.; Huang Y.-L.; Yu C.-J.; Chih-Hsin Yang J.; JIN-YUAN SHIH |
